BioSpace News Archive

Business

Codexis Announces CodeEvolver® Technology Transfer and License Agreement with Global Pharmaceutical Leader

Third CodeEvolver® licensing agreement with a major pharma company

May 15, 2019
·
3 min read
Business

Invitation to Presentation of Promore Pharma’s Interim Report for the First Quarter 2019

Promore Pharma AB (publ) publishes its Interim report for the first quarter 2019 at 13.00 CET on 21 May 2019.

May 15, 2019
·
1 min read
Auris Medical Announces Closing of Two US Patent Acquisitions Related to the Use of Betahistine for the Treatment of Depression and ADHD

Auris Medical Holding Ltd. today announced the successful closing of the purchase of two US patents related to the use of betahistine for the treatment of depression and attention-deficit / hyperactivity disorder (ADHD).

May 15, 2019
·
7 min read
Deals

Auris Medical Announces Closing of Public Offering of Common Shares

Auris Medical Holding Ltd. announced today the closing of its previously announced underwritten public offering

May 15, 2019
·
5 min read
Genetown

Definitive Healthcare Expands Commercial Claims Platform to Include Rx Data

Never-Before-Seen Integration Contextualizes Billions of Commercial Medical & Rx Claims, Empowering Users to Analyze Market Trends and Drive Business Strategies

May 15, 2019
·
4 min read
Drug Development

Are Phages the Wave of the Future? Using Viruses to Treat Bacterial Diseases

A bacteriophage is a virus that infects bacteria. They aren’t typically used to treat bacterial infections, but in desperate cases, they have been used to treat particularly antibiotic-resistant infections.

May 15, 2019
·
3 min read
·
Mark Terry
Business

A Mathematical Model Makes Earlier Detection of CVD Possible

Early detection of cardiovascular disease is becoming possible due to research from Giovanna Guidoboni, Marjorie Skubic and a team at the University of Missouri.

May 15, 2019
·
4 min read
·
Elizabeth Glasure
BioMidwest

Cincinnati Startup Raises $50 Million to Advance Hypertension Treatment Licensed from Roche

CinCor plans to advance the therapeutic through proof-of-concept Phase II clinical trials in treatment resistant hypertension and primary aldosteronism.

May 15, 2019
·
2 min read
·
Alex Keown
Business

Vertex Establishes $70 Million Protein Degradation Partnership with Kymera Therapeutics

The move by Vertex is part of the company’s plan to diversify its drug discovery strategies.

May 15, 2019
·
3 min read
·
Alex Keown
BioSpace Global Roundup, May 16

Pharma and biotech companies from across the globe provide business and pipeline updates, with news from Gecko, ValGenesis, NeuClone, Zymeworks, and more.

May 15, 2019
·
5 min read
·
Alex Keown